It's been just a little over 2 months since I planned to sell half my OWCP for a tax loss, then they announced patent approval. We had a substantial gain, but have given back much of it, but nowhere near the sub penny price we were before the announcement.
I made the decision that holding is worthwhile, I'm not worried about the day to day weakness, especially when coronavirus is killing the market. Am I adding to my position, if I had access funds I'd consider it, but not yet. What I do believe is that sometime later this year the company will finally give us another comprehensive update, then we can truly evaluate what we believe the potential is.
Right now, all we know is the skin cream will be further tested, and we believe that further testing of the sublingual tablet is anticipated as well. I believe before substantial funds are put out on the sublingual tablet, they need to know that they've still got a shot at patent approval.
I cannot tell you this stock will go to a dime, a dollar, or ten dollars, but I certainly believe it has that potential and more. Just the cream alone if approved as a drug by our FDA and other International regulators could potentially be a blockbuster drug. Even if OWCP partners the drug and only sees 10% of sales, what would $100 million in earnings do for the company. With the current shares outstanding, that would equate to about $.35 a share, with a P/E of 10, that's $3.50 if the P/E's 30, it's over $10. It could certainly be worth more than that, especially if additional patents come through, and of course if it's found effective against many skin disease, not just psoriasis, it could be a blockbuster many times over.
Gary
